Foreign and domestic licensing deals for innovative pharmaceuticals in China
Overseas licenses for Chinese drugs now constitute nearly half of all deals, while the share of imports has fallen drastically over the last decade.
The column chart shows the share of foreign (both exports and imports) and domestic licensing deals for innovative pharmaceutical from 2015 through 2025.
